vs
Side-by-side financial comparison of GRAHAM CORP (GHM) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $56.7M, roughly 1.0× GRAHAM CORP). GRAHAM CORP runs the higher net margin — 5.0% vs -83.0%, a 88.0% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 20.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 7.5%).
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
GHM vs RYTM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.7M | $57.3M |
| Net Profit | $2.8M | $-47.5M |
| Gross Margin | 23.8% | 91.6% |
| Operating Margin | 5.5% | -82.2% |
| Net Margin | 5.0% | -83.0% |
| Revenue YoY | 20.5% | 36.9% |
| Net Profit YoY | 79.2% | -9.6% |
| EPS (diluted) | $0.25 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.7M | $57.3M | ||
| Q3 25 | $66.0M | $51.3M | ||
| Q2 25 | $55.5M | $48.5M | ||
| Q1 25 | $59.3M | $32.7M | ||
| Q4 24 | $47.0M | $41.8M | ||
| Q3 24 | $53.6M | $33.3M | ||
| Q2 24 | $50.0M | $29.1M | ||
| Q1 24 | $49.1M | $26.0M |
| Q4 25 | $2.8M | $-47.5M | ||
| Q3 25 | $3.1M | $-52.9M | ||
| Q2 25 | $4.6M | $-46.6M | ||
| Q1 25 | $4.4M | $-49.5M | ||
| Q4 24 | $1.6M | $-43.3M | ||
| Q3 24 | $3.3M | $-43.6M | ||
| Q2 24 | $3.0M | $-32.3M | ||
| Q1 24 | $1.3M | $-141.4M |
| Q4 25 | 23.8% | 91.6% | ||
| Q3 25 | 21.7% | 89.3% | ||
| Q2 25 | 26.5% | 88.6% | ||
| Q1 25 | 27.0% | 88.8% | ||
| Q4 24 | 24.8% | 90.9% | ||
| Q3 24 | 23.9% | 88.5% | ||
| Q2 24 | 24.8% | 89.9% | ||
| Q1 24 | 25.9% | 89.2% |
| Q4 25 | 5.5% | -82.2% | ||
| Q3 25 | 6.5% | -102.6% | ||
| Q2 25 | 8.9% | -93.4% | ||
| Q1 25 | 9.3% | -143.7% | ||
| Q4 24 | 4.7% | -98.6% | ||
| Q3 24 | 7.9% | -132.0% | ||
| Q2 24 | 6.5% | -139.2% | ||
| Q1 24 | 3.1% | -538.7% |
| Q4 25 | 5.0% | -83.0% | ||
| Q3 25 | 4.7% | -103.1% | ||
| Q2 25 | 8.3% | -96.1% | ||
| Q1 25 | 7.4% | -151.4% | ||
| Q4 24 | 3.4% | -103.6% | ||
| Q3 24 | 6.1% | -131.2% | ||
| Q2 24 | 5.9% | -110.9% | ||
| Q1 24 | 2.7% | -544.4% |
| Q4 25 | $0.25 | $-0.73 | ||
| Q3 25 | $0.28 | $-0.82 | ||
| Q2 25 | $0.42 | $-0.75 | ||
| Q1 25 | $0.40 | $-0.81 | ||
| Q4 24 | $0.14 | $-0.71 | ||
| Q3 24 | $0.30 | $-0.73 | ||
| Q2 24 | $0.27 | $-0.55 | ||
| Q1 24 | $0.11 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.3M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $131.3M | $139.1M |
| Total Assets | $292.9M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.3M | $388.9M | ||
| Q3 25 | $20.6M | $416.1M | ||
| Q2 25 | $10.8M | $291.0M | ||
| Q1 25 | $21.6M | $314.5M | ||
| Q4 24 | $30.0M | $320.6M | ||
| Q3 24 | $32.3M | $298.4M | ||
| Q2 24 | $21.6M | $319.1M | ||
| Q1 24 | $16.9M | $201.2M |
| Q4 25 | $131.3M | $139.1M | ||
| Q3 25 | $127.6M | $148.8M | ||
| Q2 25 | $123.4M | $-11.9M | ||
| Q1 25 | $119.6M | $18.9M | ||
| Q4 24 | $114.4M | $21.7M | ||
| Q3 24 | $112.5M | $11.2M | ||
| Q2 24 | $108.2M | $39.3M | ||
| Q1 24 | $105.6M | $61.6M |
| Q4 25 | $292.9M | $480.2M | ||
| Q3 25 | $287.0M | $506.9M | ||
| Q2 25 | $252.3M | $372.7M | ||
| Q1 25 | $264.1M | $386.7M | ||
| Q4 24 | $264.3M | $392.3M | ||
| Q3 24 | $249.5M | $363.6M | ||
| Q2 24 | $244.2M | $381.8M | ||
| Q1 24 | $233.9M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.8M | $-25.4M |
| Free Cash FlowOCF − Capex | $2.4M | — |
| FCF MarginFCF / Revenue | 4.3% | — |
| Capex IntensityCapex / Revenue | 4.1% | — |
| Cash ConversionOCF / Net Profit | 1.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.8M | $-25.4M | ||
| Q3 25 | $13.6M | $-26.6M | ||
| Q2 25 | $-2.3M | $-23.3M | ||
| Q1 25 | $-3.6M | $-40.4M | ||
| Q4 24 | $5.2M | $-18.8M | ||
| Q3 24 | $13.9M | $-25.2M | ||
| Q2 24 | $8.7M | $-29.1M | ||
| Q1 24 | $8.6M | $-40.7M |
| Q4 25 | $2.4M | — | ||
| Q3 25 | $9.4M | — | ||
| Q2 25 | $-9.3M | — | ||
| Q1 25 | $-8.7M | — | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $5.7M | — | ||
| Q1 24 | $4.6M | — |
| Q4 25 | 4.3% | — | ||
| Q3 25 | 14.3% | — | ||
| Q2 25 | -16.7% | — | ||
| Q1 25 | -14.7% | — | ||
| Q4 24 | -4.5% | — | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 11.5% | — | ||
| Q1 24 | 9.4% | — |
| Q4 25 | 4.1% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 12.6% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 15.6% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 8.2% | — |
| Q4 25 | 1.67× | — | ||
| Q3 25 | 4.40× | — | ||
| Q2 25 | -0.49× | — | ||
| Q1 25 | -0.81× | — | ||
| Q4 24 | 3.29× | — | ||
| Q3 24 | 4.25× | — | ||
| Q2 24 | 2.94× | — | ||
| Q1 24 | 6.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
RYTM
Segment breakdown not available.
